Skip to main content

Table 3 Agreement achieved by the experts after the two rounds (Topic 3)

From: Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients

  Median
(IQR)
Agreement
(%)
Topic 3. Quality of life of cancer patients with OIC
46. OIC negatively affects the quality of life of patients with cancer. 9 (1) 97.88
47. Poor OIC control can negatively affect adherence to pain management, affecting the quality of life of patients with cancer. 9 (1) 95.74
48. The simplification of the dosage of oral treatments in a single daily dose contributes to improve the quality of life of patients with OIC. 9 (1) 93.61
49. It is important to consider the opinion of patients about improving their quality of life when assessing the efficacy of treatment. 9 (1) 100.00
50. It is important to consider the opinion of patients on the evolution of their symptoms when assessing the efficacy of treatment. 9 (1) 100.00
51. The routine use in clinical practice of symptom monitoring tools that include patient feedback may be good for anticipating the implementation of therapeutic actions that prevent the onset of severe symptoms. 8 (2) 91.49
52. The routine use in clinical practice of symptom monitoring tools that include patient feedback may ontribute to improving their quality of life. 9 (1) 93.61
53. Quality of life is a key element to be prioritized in the comprehensive approach to oncology patients with OIC. 9 (1) 100.00
  1. IQR interquartile range, OIC opioid-induced constipation